Cytosaminomycin C
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-01142 |
CAS | 157878-04-1 |
Molecular Weight | 496.55 |
Molecular Formula | C23H36N4O8 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Streptomyces sp. KO-8119. It has anti-eimeria Tenella activity. The concentration of Cytosaminomycin C without cleavage in chicken embryo cells is 0.3-0.6 μg/mL.
- Specification
- Properties
- Reference Reading
- Price Product List
IUPAC Name | N-[1-[(2R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-5-(dimethylamino)-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]-2-oxopyrimidin-4-yl]-3-methylbut-2-enamide |
Canonical SMILES | CC1C(C(C(C(O1)OC2C(OC(CC2O)N3C=CC(=NC3=O)NC(=O)C=C(C)C)C)O)O)N(C)C |
InChI | InChI=1S/C23H36N4O8/c1-11(2)9-16(29)24-15-7-8-27(23(32)25-15)17-10-14(28)21(13(4)33-17)35-22-20(31)19(30)18(26(5)6)12(3)34-22/h7-9,12-14,17-22,28,30-31H,10H2,1-6H3,(H,24,25,29,32)/t12-,13-,14-,17-,18-,19+,20-,21-,22-/m1/s1 |
InChI Key | QIFBWQHIMSOVGC-NJGLGVPISA-N |
Appearance | White Powder |
Solubility | Soluble in Methanol |
BBF-03891 | Cefsulodin sodium | Inquiry |
BBF-00852 | Epothilon B | Inquiry |
BBF-05843 | Bacitracin | Inquiry |
BBF-03904 | Nosiheptide | Inquiry |
BBF-02800 | DB-2073 | Inquiry |
BBF-05817 | Astaxanthin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
